Human Immunodeficiency Virus Type 1 Infection and Myopathy:Clinical Relevance of Zidovudine Therapy
Ann Neurol 34:206-211, Grau,J.M.,et al, 1993
Myopathies Assoc with HIV and Zidovudine:Can Their Effects be Distinguished?
Neurol 43:971-976, Simpson,D.M.,et al, 1993
Depletion of Muscle Mitochondrial DNA in AIDS Patients with Zidovudine-Induced Myopathy
Lancet 337:508-510, Arnaudo,E.,et al, 1991
Myopathy in Human Immunodeficiency Virus-Infected Children Receiving Long-Term Zidovudine Therapy
J Pediatr 119:152-155, Walter,E.B.,et al, 1991
Zidovudine Myopathy:A Distinctive Disorder Associated with Mitochondrial Dysfunction
Ann Neurol 29:606-614, Mhiri,C.,et al, 1991
Myopathy with Human Immunodeficiency Virus Type I (HIV-1) Infection:HIV-1 or Zidovudine?
Ann Int Med 113:492-493, Till,M.&MacDonell,K., 1990
Severe Polymyositis-Like Syndrome Associated with Zidovudine Therapy of AIDS & ARC
NEJM 318:708, Bessen,L.J.,et al, 1988
Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy
NEJM 381:275-283, Case 22-2019, 2019
Investigation of Muscle Disease
JNNP 60:256-274, Mastaglia,F.L.&Laing,N.G., 1996
Sudden Onset of Profound Weakness in a Toddler
J Pediatr 122:663-667, Carraccio,C.,et al, 1993